GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
133.12
-2.82 (-2.07%)
Dec 18, 2025, 2:35 PM EST - Market open
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.85 billion as of December 18, 2025. Its market cap has increased by 78.68% in one year.
Market Cap
3.85B
Enterprise Value
3.90B
1-Year Change
78.68%
Ranking
Category
Stock Price
$133.12
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.85B, a decrease of -78.50%. That is a compound annual growth rate of -25.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 4.10B | 94.01% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.51B |
| Johnson & Johnson | 502.24B |
| AbbVie | 397.13B |
| UnitedHealth Group | 296.85B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 249.00B |
| Abbott Laboratories | 218.48B |